Estraderm combined with Estradiol

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Progesterone Receptor Assay Positive Other Serious 1/1/1996 Female 1/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1996 Female 1/27/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Ultrasound Scan Abnormal Other Serious 11/20/2002 48 Female 148 lb 6/12/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/1996 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/15/2000 67 Female 155 lb 10/10/2006 United States
Primary
Secondary
Scar Other Serious Female 9/18/2006 Lawyer United States
Primary
Secondary
Concomitant
Venous Insufficiency Other Serious 8/15/1999 54 Female 118 lb 3/17/2007
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 12/22/2006 United States
Primary
Secondary
Tricuspid Valve Incompetence Other Serious 6/3/2003 64 Female 150 lb 4/24/2007 United States
Primary
Secondary
Concomitant
Vulvovaginal Dryness Other Serious 10/20/1992 49 Female 126 lb 4/26/2007 United States
Primary
Secondary
Concomitant
Radiotherapy Other Serious 4/22/1994 57 Female 135 lb 5/10/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Uterine Prolapse Other Serious 1/1/1988 60 Female 190 lb 6/14/2007 United States
Primary
Secondary
Concomitant
Vascular Purpura Other Serious 7/1/2002 55 Female 8/3/2007 Pharmacist France
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 10/8/2007 Consumer United States
Primary
Secondary
Polypectomy Other Serious 8/15/1999 54 Female 118 lb 11/3/2007
Primary
Secondary
Tricuspid Valve Incompetence Other Serious 6/3/2003 64 Female 150 lb 11/15/2007 United States
Primary
Secondary
Concomitant
Vulvovaginal Dryness Other Serious 10/20/1992 49 Female 126 lb 11/17/2007 United States
Primary
Secondary
Concomitant
Ventricular Extrasystoles Other Serious 10/23/1995 65 Female 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Uterine Prolapse Other Serious 1/1/1988 60 Female 190 lb 12/3/2007 United States
Primary
Secondary
Concomitant
Scrotal Disorder Congenital Anomaly 1/29/2008 United Kingdom
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 9/22/2003 Female 3/31/2008 Consumer United States
Primary
Secondary
Impaired Healing Other Serious 11/20/2002 48 Female 148 lb 6/6/2006 Pharmacist United States
Primary
Secondary
Concomitant
Tricuspid Valve Incompetence Other Serious 6/3/2003 64 Female 150 lb 4/21/2008 United States
Primary
Secondary
Concomitant
Uterine Prolapse Other Serious 1/1/1988 60 Female 190 lb 4/23/2008 United States
Primary
Secondary
Concomitant
Visual Disturbance Other Serious 1/1/1990 Female 160 lb 6/13/2008 United States
Primary
Secondary
Concomitant
Uterine Prolapse Other Serious 1/1/1988 Female 190 lb 6/16/2008 United States
Primary
Secondary
Concomitant
Uterine Prolapse Other Serious 1/1/1988 Female 190 lb 7/30/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/1/2002 48 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 12/2/1996 60 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1999 64 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/15/2000 67 Female 155 lb 10/9/2008 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/13/2001 Female 12/3/2008 Lawyer United States
Primary
Secondary
Vein Disorder Other Serious 8/15/1999 Female 118 lb 1/14/2009 United States
Primary
Secondary
Concomitant
Injury Other Serious Female 1/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/21/1999 56 Female 12/19/2008 United States
Primary
Secondary
Vomiting Hospitalization Female 1/28/2009 Consumer Australia
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/13/2004 Female 2/12/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/22/2003 Female 3/3/2009 Other Health Professional United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 Female 4/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 7/10/2002 Female 170 lb 5/15/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/1999 Female 5/15/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/10/1997 Female 6/24/2009 Lawyer United States
Primary
Secondary
Concomitant
Tricuspid Valve Incompetence Other Serious 6/3/2003 Female 150 lb 7/2/2009 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/10/1997 Female 7/27/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/1999 Female 8/5/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 65 Female 8/17/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2003 Female 9/23/2009 Lawyer United States
Primary
Secondary
Concomitant
Vomiting Hospitalization 53 Female 9/24/2009 United States
Primary
Concomitant
Vomiting Hospitalization 53 Female 11/4/2009 United States
Primary
Concomitant
Tricuspid Valve Incompetence Other Serious 6/3/2003 Female 150 lb 11/18/2009 United States
Primary
Secondary
Concomitant
Vulvovaginal Dryness Other Serious 10/20/1992 Female 126 lb 11/19/2009 Other Health Professional United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious Female 11/30/2009 Lawyer United States
Primary
Secondary
Concomitant
Venous Valve Ruptured Other Serious 8/15/1999 Female 118 lb 11/30/2009 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious Female 2/1/2010 Lawyer United States
Primary
Secondary
Concomitant
Tricuspid Valve Incompetence Other Serious 6/3/2003 Female 150 lb 2/22/2010 United States
Primary
Secondary
Concomitant
Visual Impairment Other Serious 1/1/1990 Female 160 lb 3/3/2010 United States
Primary
Secondary
Concomitant
Weight Increased Hospitalization 53 Female 4/15/2010 United States
Primary
Concomitant
Visual Impairment Other Serious 1/1/1990 47 Female 160 lb 5/19/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 57 Female 150 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/20/2002 48 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/15/2000 67 Female 155 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/1/2004 61 Female 121 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/16/2000 57 Female 115 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/1999 64 Female 119 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2007 58 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/24/1999 51 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/24/1999 51 Female 6/24/2010 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/16/2000 57 Female 115 lb 6/24/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 9/1/2004 61 Female 121 lb 6/24/2010 Lawyer United States
Primary
Secondary
Concomitant
Vertigo Other Serious 8/15/1999 53 Female 118 lb 7/7/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/1996 Female 7/26/2010 Lawyer United States
Primary
Secondary
Vertigo Other Serious 8/15/1999 53 Female 118 lb 8/21/2010 United States
Primary
Secondary
Concomitant
Vulvovaginal Dryness Other Serious 10/20/1992 44 Female 126 lb 9/3/2010 United States
Primary
Secondary
Concomitant
Vertigo Other Serious 8/15/1999 53 Female 118 lb 9/6/2010 United States
Primary
Secondary
Concomitant
Vertigo Other Serious 8/15/1999 53 Female 118 lb 9/14/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/1999 Female 9/16/2010 Consumer United States
Primary
Secondary

Drug Data